**Question:** Bad prognosis is indicated in multiple myeloma by -

A. Bone marrow plasma cell infiltration > 90%
B. Serum calcium level > 12 mg/dL
C. Serum albumin level < 3.5 g/dL D. Serum creatinine level 90%). In this condition, the malignant plasma cells outnumber the normal plasma cells and interfere with normal hematopoiesis, leading to impaired immune system function and increased risk of complications.

**Why Each Wrong Option is Incorrect:**

Option B (serum calcium level > 12 mg/dL) is incorrect because hypercalcemia is a common complication of multiple myeloma due to the release of parathyroid hormone-related protein (PTHrP) by the malignant plasma cells. However, hypercalcemia alone is not a prognostic factor but rather a consequence of the disease.

Option C (serum albumin level < 3.5 g/dL) is incorrect because hypoalbuminemia is a common finding in advanced stages of multiple myeloma due to liver dysfunction or malnutrition. Hypoalbuminemia does not specifically indicate bad prognosis in multiple myeloma. Option D (serum creatinine level 90%) is the correct answer because a high percentage of plasma cell infiltration indicates a more aggressive disease. This infiltration leads to impaired bone marrow function, increased risk of complications, and reduced overall survival in patients with multiple myeloma.

**Clinical Pearl:**

A poor prognosis in multiple myeloma is associated with a combination of factors, including advanced age, anemia, renal impairment, hypercalcemia, and hyperviscosity. The presence of these factors should prompt a thorough workup for multiple myeloma.

**Explanation of each wrong option:**

Option B (hypercalcemia) is not specific to poor prognosis in multiple myeloma and can be present due to parathyroid hormone-related protein (PTHrP) production by the malignant plasma cells in advanced myeloma.

Option C (hypoalbuminemia) is not specific to poor prognosis in multiple myeloma and can be caused by liver dysfunction or malnutrition, both of which may be present in advanced stages of multiple myeloma.

Option D (renal impairment) is not specific to poor prognosis in multiple myeloma and can be caused by direct renal involvement by the tumor or by hyperviscosity